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Nucling, a Novel Apoptosis-associated Protein, Controls
Mammary Gland Involution by Regulating NF-B and STAT3*
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Background: Nucling is identified as a novel regulator of apoptosis, but its roles in mammary gland remains unknown.
Results: Loss of Nucling led to an inhibited apoptosis and impaired mammary gland involution.
Conclusion: Nucling controlled NF-B and STAT3 activities to mediate involution.
Significance: Elucidation of the physiological role of Nucling in this process may provide useful insight into breast cancer
therapy.
Postpartum mammary gland involution is the physiological
process by which the lactating gland returns to its pre-pregnant
state. In rodent models, the microenvironment of mammary
gland involution is sufficient to induce enhanced tumor cell
growth, local invasion, and metastasis. Therefore, a deeper
understanding of the physiological regulation of involutionmay
provide in-depth information on breast cancer therapy. We
herein identified Nucling as an important regulator of involu-
tion of themammary gland. A knock-outmousemodel was gen-
erated and revealed that postpartum involution were impaired
in mice lacking Nucling. Involution is normally associated with
an increase in the activation of NF-B and STAT3, which is
required for the organized regulation of involution, and was
observed in WT glands, but not in the absence of Nucling. Fur-
thermore, the loss of Nucling led to the suppression of Cal-
pain-1, IL-6, and C/EBP factors, which are known to be essen-
tial for normal involution. The number of M2 macrophages,
which are crucial for epithelial cell death and adipocyte repopu-
lation after weaning, was also reduced in Nucling-KO glands.
Taken together, the results of the present study demonstrated
that Nucling played an important role in mammary gland invo-
lution by regulating NF-B and STAT3 signaling pathways.
Mammary gland development continues undergoing dy-
namic changes after puberty with each cycle of pregnancy, lac-
tation, and involution (1). Involution involves the regression of
the lactation stage after weaning, and has been described as a
two-step process. The first phase lasts 48 h, starts immediately
upon weaning, and is associated with apoptosis and shedding
cells in the lumen. The second phase begins 48 h after weaning
and is characterized by marked changes in mammary gland
architecture including the collapse of the lobular-alveolar
structure and repopulation of adipocytes (2, 3). During the first
stage of involution, milk stasis has been shown to induce the
expression and secretion of the pro-inflammatory cytokine leu-
kemia inhibitory factor (LIF).4 LIF binds to the heterodimer of
the LIF receptor and gp130. The signal-transducing subunit
gp130 is responsible for the intracellular activation of the JAK/
STAT3 signaling pathway, which is indispensable for the initi-
ation of involution (4–6). In the absence of STAT3, apoptosis
was found to be markedly repressed and the first phase was
abolished (7, 8). However, the activation of STAT3 is insuffi-
cient to induce involution in the absence of NF-B signaling.
During mammary gland development, the activation of NF-B
increases during pregnancy, decreases during lactation, and
then increases again after weaning (9, 10). The loss of NF-B
signaling has been shown to result in a decrease in caspase-3
cleavage and delayed involution (11). In contrast, a previous
study demonstrated that constitutively active IKK- increased
NF-B activation, leading to a reduction in milk protein levels
and increases the level of apoptosis during involution (10).
Phagocytosis is a crucial contributor to the remodeling pro-
cess and removal of cell debris and residual milk in the second
phase of involution (12, 13). Furthermore, a recent study dem-
onstrated thatmammary gland involutionwas characterized by
the recruitment ofmacrophageswithM2characteristics, which
is crucial for epithelial cell death and adipocyte repopulation
(14).
Nucling was originally isolated from murine embryonic
carcinoma cells as a novel protein, and its up-regulated
expression was observed during cardiac muscle differentia-
tion (15). Nucling was also shown to recruit and transport the
Apaf1pro-caspase-9apoptosome complex during stress-in-
duced apoptosis (16, 17). In addition, we previously reported
that Nuclingmediated apoptosis by suppressing the expression
of the anti-apoptotic molecule galectin-3 via NF-B signaling
(18). Apoptosis has been identified as a crucial part of involu-
tion in the mammary gland (13). However, it currently remains
unknown whether Nucling controls apoptosis in mammary
gland involution.
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Previous studies reported that Nucling negatively regulated
the translocation of NF-B into the nucleus (19, 20, 21). How-
ever, Nucling is not only a suppressor of NF-B in resting cells,
but is also an up-regulator of NF-B in stimulated cells (20).
Furthermore, NF-B signaling is required for normal mam-
mary gland involution; therefore, it has not yet been deter-
mined whether Nucling is a suppressor or inducer of the acti-
vation of NF-B in this context. We previously demonstrated
that Nucling controlled the population of Kupffer cells in the
liver, which act as phagocytes or antigen-presenting cells (22).
However, the influence of Nucling onmacrophage recruitment
in mammary gland involution has not yet been elucidated.
Postpartum mammary gland involution has been identified
as tumor promotional and is proposed to contribute to
increased rates of metastasis and poor survival in postpartum
breast cancer patients (23). Therefore, a deeper understanding
of the regulation of involution is important for breast cancer
therapy. The potential contribution of Nucling to mammary
gland physiology has not yet been examined in detail. There-
fore, the aim of the present study was to investigate the physi-
ological role of Nucling in mammary gland involution and elu-
cidate the possible signaling pathway. We demonstrated that
Nucling was strongly expressed during involution, and the loss
of Nucling resulted in delayed involution. Furthermore, mam-
mary gland involution was controlled by Nucling through the
regulation of crucial NF-B and STAT3 signaling pathways.
Experimental Procedures
Induction of Involution and Tissue Processing—Nucling-KO
mice were described previously (16). Adult female mice (12–15
weeks of age) weremated. The induction of involution has been
previously described (24). The thoracic glands were snap-fro-
zen in nitrogen liquid to extract RNA and protein for quantita-
tive real-time PCR and Western blotting. The inguinal glands
were fixed in 4% paraformaldehyde and embedded in paraffin.
The embedded tissues were sectioned at a thickness of 5 m
for staining with hematoxylin/eosin, tunnel assays, and
immunofluorescence.
Whole Mount Carmine-stained Mammary Glands—Ingui-
nal mammary glands were fixed in Carnoy’s solution, stained in
carmine (Sigma catalog number C-1022) solution overnight,
rinsed in alcohol, cleared in xylene, and mounted with per-
mount under a coverslip. Whole mount images were taken
using aMultizoomAZ100Mmicroscope with an Imaging Soft-
ware NIS-Elements (Nikon, Japan).
Quantitative Real-time PCR—Total RNA for relative quanti-
fication was isolated using Isogen (Nippogene catalog number
211-02501) following the manufacturer’s recommendations.
First-strand cDNA was synthesized using a Superscript
VILOTM cDNA Synthesis Kit (Invitrogen catalog number
11754-050). Quantitative RT-PCR was performed with SYBR
Premix Ex TaqTM II (Takara) using a 7500 real-time PCR sys-
tem (Applied Biosystems) according to the manufacturer’s
instructions. GAPDH used as an internal control. The follow-
ing primers were use: IL-6, 5-TCCATCCAGTTGCCTTCT-
TGG-3 and 5-TCTGCAAGTGCATCATCGTTG-3; -
casein, 5-GCTCAGGCTCAAACCATCTC-3 and 5-TGTGG-
AAGGAAGGGTGCTAC-3; Calpain-1, 5-ACCACATTTTA-
CGAGGGCAC-3 and 5-GGATCTTGAACTGGGGGTTT-
3; C/EBP, 5-ACCCGCGGCCTTCTACGA-3 and 5-
GCGCCCTTTTCTCGGACTGT-3; LIF, 5-GGCTCTGGA-
ACCTTGGGCAAAACTG-3 and 5-GCCTGCACTGCTCC-
AACCTCCTGTA-3; gp-130, 5-TCGGAGGAGCGGCCAGA-
AGAC-3 and 5-ATCAGCCCCCGTGCCAAGAGC-3; Sim2s,
5-AACCAGCTCCCGTGTTTGAC-3 and 5-CTCTGAGGA-
ACGGCGAAAA-3; GAPDH, 5-TGTGTCCGTCGTGGATC-
TGA-3 and 5-CCTGCTTCACCACCTTCTTGA-3.
Tunnel Staining—Paraffin-embedded sections were dewaxed,
rehydrated, and stained according to themanufacturer’s protocol
of the In Situ Cell Death Detection Kit with fluorescein (catalog
number 11-684-795-910; Roche Applied Science).
Immunofluorescence—Slideswere deparaffinizedwith xylene
and dehydratedwith graded alcohol, and boiled for 15min in 10
nM sodium citrate, pH 6.0. The sections were blocked with 5%
normal goat serum and incubated with rabbit anti-mouse argi-
nase-1 antibody (ab91279), and rabbit anti-mouse Ym1 anti-
body (ab93034) at 4 °C for 24 h. The antibodies were diluted
following the manufacturer’s recommendations. The sections
were then incubated with Alexa Fluor 594 goat anti-rabbit IgG
antibody (Invitrogen), 1:400, diluted in blocking solution for 1 h
at room temperature. Slides were coverslipped in mounting
medium for fluorescence with DAPI (Vector Laboratories, Inc.,
Burlingame, CA). Images were viewed by using BZ-9000 Fluo-
rescence Microscope (KEYENCE Corp. of America).
Protein Isolation and Western Blotting—Total protein was
extracted from snap-frozen glands by homogenization in 2 ml
of extraction buffer (25 mM Tris, pH 7.4, 150 mMNaCl, 0.5 mM
sodium vanadate, 50 mM sodium fluoride, 10 mM sodium pyro-
phosphate) and 1 mM phenylmethylsulfonyl fluoride with a
protease inhibitor (catalog number 05892970001, Roche) and
phosphatase inhibitor (catalog number 04960845001, Roche).
Proteins were isolated as described previously (25). Protein
concentrations were determined using the BCATM Protein
Assay Kit (Pierce). Western blotting was performed as
described previously (26). The following antibodies were used:
anti-mouse middle portion of Nucling (m.Nucl.mid) (16); a
phospho-NF-B-p65 (Ser-468) antibody (Cell Signaling); a
phospho-STAT3 (Tyr-705) mouse antibody (Cell Signaling);
caspase-3 antibody (Santa Cruz); a STAT3 antibody (sc482
Santa Cruz); anti-liver Arginase antibody (ab91279, Abcam);
monoclonal anti--actin (catalog number A5441, Sigma); HRP
anti-mouse IgG (catalog numberNA9310, GEHealthcare); and
HRP anti-rabbit IgG (catalog number NA934, GE Healthcare).
Data Analyses—Images of whole mount carmine staining
and immunoblots were quantified using ImageJ software. Rel-
ative mRNA levels were quantified by using the 2∧(Ct)
method. Statistical analyses were conducted using a two-tailed
Student’s t test.
Results
Nucling-KO Mice Exhibited Normal Mammary Gland De-
velopment, but Defective Involution—Before addressing the
importance of Nucling during involution, we investigated
whether this gene was required for mammary gland puberty,
pregnancy, and lactation.We analyzed the whole mount mam-
mary gland outgrowths of Nucling-KO and WT animals at 10
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weeks and confirmed that the loss of Nucling did not affect
mammary gland development in pubertalmice (Fig. 1,A andB).
Furthermore, whole mount analyses of Nucling-KO mice
showed a normal pregnancy, as indicated by similar ductal
areas and densities of branches/lobules at pregnancy to those of
WT mice (Fig. 1, C and D). To exclude the possibility that
Nucling was essential for lactation, whole mount staining of
glands at lactation day 10 demonstrated the identical gross
morphologies of Nucling-KO mice and the controls (Fig. 2A).
Furthermore, pups derived fromNucling-KO females were sta-
ble and reached adulthood without any signs of a decrease in
weight or health. These results confirmed the normal lactation
of Nucling-KO mice. However, a decrease in the densities of
branches/lobules were slower in Nucling-KO glands than in
WT glands 72 and 120 h after weaning (Fig. 2, A and B). This
result suggested that Nuclingmay play an important role in the
regulation of mammary gland involution.
Nucling-KO Mammary Glands Displayed Delayed Invo-
lution—AsNucling affected the regression of mammary glands
after weaning, we analyzed histological changes in Nucling-KO
glands using H&E staining. No significant differences were
observed in the histoarchitectural morphology of lactating
glands in Nucling-KOmice andWTmice. However, the loss of
Nucling had marked effects on involution. Fewer epithelium
cells were shed into the lumen in Nucling-KO mice at 36 h of
involution (Fig. 3A). As expected, the delayed involution
observed in Nucling-KO mice correlated with a significantly
lower number of apoptotic epithelial cells at 36 h of involution,
as assessed by a TUNEL assay (Fig. 3, B and C). After 72 h of
weaning,WTmammary glands had undergone extensive tissue
remodeling, characterized by the collapse of the lobular-alveo-
lar structure. In contrast, open alveolar structures persisted and
the reappearance of adipocytes was slower inNucling-KOmice
than inWTmice (Fig. 3A). This was accompanied by a decrease
FIGURE 1. Nucling-KO mammary glands showed normal morphologies in pubertal and pregnant mice. Representative whole mount carmine-stained
mammary glands fromWT andNucling-KOmice at (A) PND70 and (C) pregnancy day 16. Scale bars represent 2,000m. B, quantification of the ductal area and
growth past the lymph node at PND70 (postnatal day 70). D, quantification of the ductal area and the density of branches/lobules at pregnancy day 16. The
ductal areawasmeasured as the area occupied by the entiremammary gland at PND70 and pregnancy day 16. The length of growth past the lymph nodewas
measured by determining the distance from the lymphnode to the tip of the longest duct. The density of branches/lobuleswasmeasured as the density of the
areaoccupiedby theentiremammaryglandatpregnancyday16.Datawerenormalizedwith thoseofWTmiceand representmeanS.D. (n5pergenotype,
per age group). NS, not significant.
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in the presence of cleaved caspase-3 in Nucling-KO mice (Fig.
3,D and E). The other indication of mammary gland involution
is a reduction in milk production. Therefore, RT-PCR was per-
formed to determine whether Nucling affected the expression
of -casein mRNA after weaning. Reductions in -casein
mRNA levels inmammary glands occurred later inNucling-KO
mice than in WT mice (Fig. 3F). Taken together, these results
showed that the loss of Nucling during involution delayed invo-
lution of the mammary gland.
Overexpression of Nucling during Mammary Gland In-
volution—Because Nucling is important for the regulation of
involution, we attempted to elucidate howNucling is expressed
in the mammary gland. Therefore, the expression of Nucling
was examined in the mammary gland at various developmental
stages byWestern blotting. As shown in Fig. 4,A andB, Nucling
was weakly expressed in pubertal glands. Its expression was
up-regulated in pregnancy, down-regulated in the lactation
stage, and increased after the glands underwent involution.
The NF-B Signaling Pathway Was Impaired during Mam-
mary Gland Involution in Nucling-KO Mice—We found that
Nucling was strongly expressed during involution (Fig. 4,A and
B). Therefore, in an attempt to reveal the molecular mecha-
nisms underlying delayed involution in Nucling-KO mice, we
investigated the influence of Nucling on NF-B activity by ana-
lyzing the phosphorylation levels of NF-B-p65 in WT and
Nucling-KO glands using Western blotting. The results
obtained showed that the level of phosphorylated NF-B-p65
was lower in Nucling-KO mice than in WT during involution
FIGURE 2. Nucling-KO mammary glands displayed a defective morphology for postlactational involution. A, representative whole mount carmine-
stainedmammary glands fromWT andNucling-KOmice at lactation day 10 (involution 0 h) and at 36, 72, and 120 h of involution. Scale bars indicate 2,000m.
B, quantification of the density of branches/lobules in themammary gland. The density of branches/lobules wasmeasured as the density of area occupied by
the entire mammary gland at 0, 36, 72, and 120 h of involution. Data were normalized withWTmice at 0 h of involution and represent mean S.D. (n 5 per
genotype, per age group); *, p 0.05; **, p 0.01.
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(Fig. 4,C andD).We next attempted to determine whether this
suppression correlated with a decrease in the expression of
NF-B target genes, which are known to play a role during
involution.Whenwe assessed IL-6 and Calpain-1mRNA levels
by RT-PCR, we found a decrease in gene expression in
Nucling-KO glands (Fig. 4, E and F). These results suggested
that delayed involution in Nucling-KO mice was mediated, at
least in part, by theNucling-dependent regulation of theNF-B
signaling pathway.
Reduction in M2 Macrophage Recruitment in Mammary
Gland Involution in Nucling-KO Mice—Macrophages with an
alternatively activatedM2phenotype have been shown to play a
role in involution (14). We also previously reported that
Nucling affected the number of Kupffer cells in the liver (22).
Therefore, we attempted to elucidate the contribution of
Nucling to M2 macrophage recruitment during mammary
gland involution. To achieve this, we examined the expression
of Arginase-1 and Ym1, markers of M2 macrophages (14, 27).
At 36 h of involution, protein levels of Arginase-1 were similar
in WT and Nucling-KO mice. However, after 72 h of weaning,
Nucling-KO glands expressed a significantly lower level of
Arginase-1 than WT glands (Fig. 5, A and B). Then, to deter-
mine the fluctuations in M2 macrophage numbers within the
mammary gland, we performed immunofluorescence analyses
onmammary gland tissue with Arginase-1 and Ym1.We found
that there was a significantly fewer number of Arginase-1 and
Ym1 positive cells per unit area in Nucling-KO mice than in
WTmice at 72 h of involution (Fig. 5, C–F). These results sug-
gested that Nucling directly or indirectly influenced the num-
ber of M2 macrophages in the mammary gland during the sec-
ond phase of involution.
The Loss of Nucling Blocked STAT3 Activation by Repressing
gp130Expression—Arecent study reported that STAT3 activity
induced a M2 macrophage population during involution (27).
Furthermore, the activation of STAT3 after weaning was
required for normal mammary gland involution (7, 8). There-
fore, the phosphorylation levels of STAT3 was evaluated by
Western blotting to determinewhether a decline in the number
of M2 macrophages in Nucling-KO mice was related to a
decrease in the activation of STAT3. Although the expression
of STAT3 in WTmice was similar to that in Nucling-KO mice
during involution (Fig. 6, A, top panel, and B), the loss of
Nucling resulted in the suppression of STAT3 phosphorylation
during involution (Fig. 6A, lower panel). The quantification of
p-STAT3 revealed a significant decrease in the Nucling-KO
gland at 36 and 72 h of involution, illustrating the activation of
STAT3 by Nucling (Fig. 6C). This result was also confirmed by
examining the mRNA expression level of C/EBP, which is a
FIGURE 3. Loss of Nucling resulted in delayed involution. A, H&E-stainedmammary sections fromWT and Nucling-KOmice at 0, 36, and 72 h of involution.
Black arrows indicate the shedding of epithelial cells into the alveolar lumen at 36 h of involution.Dashed arrows show the lobular-alveolar structure. Asterisks
represented adipocytes. Scale bars indicate 100 m. B, TUNEL-stained mammary gland sections from WT and Nucling-KO mice at 36 h of involution. Yellow
arrows represented apoptotic epithelial cells. Scale bars indicate 300 m. C, quantification of apoptotic cells in TUNEL-stained mammary gland sections. The
number of TUNEL-positive cells in 5 random fields at200 magnification was counted. D, Western blot analysis of cleaved caspase-3 expression in WT and
Nucling-KOmammary glands at 0, 36, and 72 h of involution. E, quantification of immunoblots for cleaved caspase-3/-actin. The bar graph shows the relative
density of the bands normalized toWT at 0 h of involution. F, quantification of themRNA expression of-casein in themammary glands ofWT andNucling-KO
mice at 0, 36, and 72 h of involution by quantitative RT-PCR. Datawere normalizedwith those ofWTmice at involution of 72 h and representmean S.D. Data
were represented as mean S.D. (n 3 per genotype, per age group). *, p 0.05; **, p 0.01.
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common target gene of STAT3. C/EBP mRNA levels were
lower in Nucling-KO than in WT mice (Fig. 6D). Taken
together, these results suggested that delayed involution in
Nucling-KO mice was mediated not only through the regula-
tion of NF-B, but also STAT3 activity.
To elucidate the mechanism through which the loss of
Nucling inhibited the activation of STAT3, the expression of
LIF was examined in mammary glands. As indicated in Fig. 7A,
LIF mRNA expression was induced after weaning in WT and
Nucling-KO mice. No significant differences were observed in
LIF mRNA levels at 36 h of involution between WT and
Nucling-KO. LIF mRNA expression levels were significantly
higher inNucling-KOmice than inWTmice after 72 h ofwean-
ing. This result suggested that the suppression of STAT3 activ-
ity in Nucling-KO mice was independent of LIF expression.
Therefore, we continued to investigate the expression of gp130
mRNA because of the interaction between gp130 and the LIF-
specific receptor, which is required for the activation of STAT3
(6). We found that gp130 mRNA levels were up-regulated after
weaning in WT glands, but not in the absence of Nucling (Fig.
7B). Therefore, the inhibition of gp130 expression may be the
mechanism through which the activation of STAT3 is blocked
in Nucling-KO mice during mammary gland involution.
Furthermore, a previous study reported that Single-
minded-2s (Sim2s) regulates mouse mammary gland involu-
tion by suppression of STAT3 and NF-B (28). Therefore, RT-
PCR were performed to determine whether Nucling affects the
expression of Sim2s mRNA after weaning. We found that loss
of Nucling did not affect the reductions in Sim2smRNA levels
in mammary glands after weaning (Fig. 8). This result suggests
that Nucling may be independent from the Sim2s signaling
pathway in mammary gland involution.
Discussion
This study is the first to demonstrate that Nucling plays a
physiological role in mammary gland involution. Furthermore,
we showed that Nucling controlled postlactational involution
through not only the regulation of NF-B, but also STAT3 sig-
naling (Fig. 9).
Mammary gland proliferation is mostly observed in preg-
nancy (29). NF-B activity is essential for the proliferation of
mammary glands during pregnancy. For example, the activities
of NF-B-p65 and NF-B-p52 are suppressed in IKK-defi-
cient mice, thereby leading to incomplete pregnancies and the
lack of lactation (30). Mice lacking RANK also exhibited
impaired lobular-alveolar development in pregnancy and
defective lactation (31). RANK has been shown to mediate the
activation of both classical and alternative NF-B signaling
pathways (32). However, another study reported that the inhi-
bition of IB phosphorylation in transgenic mice with tar-
geted superrepressor IB expression decreased NF-B-p65
activity but did not affect NF-B-p52 activity, and this mouse
model showed the completion of pregnancy development (33).
These findings suggest that defective lactation due to preg-
FIGURE 4.NF-B signalingwas impaired during involution inNucling-KOmice. A, Western blot analysis of protein extracted from themammary glands of
WT and Nucling-KOmice at postnatal day (PND) 70, pregnancy day 16, and at 0, 36, and 72 h of involution was performed using antibodies against Nucling. B,
quantification of immunoblots for Nucling/-actin. The bar graph showed the relative density of the bands normalized to PND70 of WT. C, Western blot
analyses of p-NF-B-p65 expression duringmammary gland development and involution. Protein of the total cell (include cytosolic and nuclear fractions) was
extracted from the mammary gland of WT and Nucling-KO mice at PND70, pregnancy day 16, and at 0, 36, and 72 h of involution. D, quantification of
immunoblots for p-NF-B-P65/-actin. The bar graph showed the relative density of the bands normalized toWT PND70. A quantitative RT-PCR analysis of (E)
Calpain-1 and (F) IL-6mRNAexpression at 0, 36, and 72 h of involution is shown. Datawere normalizedwith those ofWTmice at 0 h of involution and represent
mean S.D. Data were represented as mean S.D. (n 3 per genotype, per age group). *, p 0.05; #, p 0.05; **, p 0.01.
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nancy incompletion occurs if both classical and alternative
NF-B signaling pathways are impaired. In the present study,
we found that Nucling-KO mammary glands showed the nor-
mal morphologies of pregnancy and lactation; however, the
activation of NF-B-p65 activity was suppressed during preg-
nancy. Therefore, this result may be attributed to the induction
of NF-B-p52 activity, which may not be affected by the loss of
Nucling. Alternately, another mechanism may compensate for
the inhibition of NF-B-p65 activity during pregnancy in
Nucling-KO mice, but further investigations are needed to
determine this. In the present study, we only focused on the
effects of Nucling on postlactational involution of the mam-
mary glands.
We previously reported that Nucling not only inhibited the
activation of NF-B in resting cells, but, in contrast, also
induced the activation of NF-B in stimulated cells (19, 20).
These findings indicated that the effects of Nucling on NF-B
signalingwere dependent on the status of the cell. In the present
study, we demonstrated that the loss of Nucling inhibited the
activation ofNF-B, leading to suppressed expression ofNF-B
target genes such as Calpain-1 and IL-6. A previous study
reported that NF-B bound to the promoter region of the Cal-
pain-1 gene and that Calpain-1 mediated epithelial cell death
during mammary gland involution though mitochondrial and
lysosomal destabilization (34). IL-6 null mice also exhibited
delayed involution and decreased apoptosis (35). We herein
found that the pattern of Nucling expression correlated with
the activation of NF-B in themammary gland from puberty to
the involution stage. These results suggest that there is an inti-
mate interaction between Nucling and NF-B signaling in the
mammary gland. We propose that Nucling is one of the target
genes of the NF-B signaling pathway; Nucling is essential for
the normal activation of NF-B, and, together these play an
important role in the regulation of postlactational involution.
Our study also revealed that the activation of STAT3 was
inhibited during mammary gland involution in the absence of
Nucling, resulting in suppressed expression of C/EBPmRNA,
which is induced by STAT3 signaling (36). C/EBP is known to
be important in the apoptotic response in mammary glands as
well as in diminished involution in C/EBP-deficient mice (37).
STAT3was previously shown to be activated after weaning and
acts as a critical regulator of apoptosis in involution (7, 8). In
addition, LIF appears to be the primary activator of STAT3-
mediated apoptosis in the mammary gland, because involution
was delayed in LIF-deficientmice and STAT3was not activated
(4, 5). STAT3 activity was suppressed despite the induction
FIGURE 5. In the absence ofNucling, the number ofM2macrophageswasdecreasedduring involution.A,Western blot analysis of Arginase-1 expression
during involution. Protein samples were prepared from the mammary glands of WT and Nucling-KOmice at 0, 36, and 72 h of involution. B, quantification of
immunoblots for Arginase-1/-actin. The bar graph shows the relative density of the bands normalized to WT at 0 h of involution. Data were represented as
mean S.D. (n 3 per genotype, per age group). #, p 0.05; *, p 0.05. Immunofluorescence of Arginase-1 (C) and Ym1 (E) as markers of M2macrophages
in mammary glands at 72 h of involution. Yellow arrows indicate Arginase-1-positive cells and yellow arrowheads indicate Ym1-positive cells. The scale bar
represents 100m.Quantification of the number of Arginase-1-positive cells (D) and Ym1-positive cells (F) in themammary glands ofWT andNucling-KOmice
at 72 h of involution. The number of Arginase-1 and Ym1-positive cells were counted in 6 randomly selected fields of eachmice at400magnification; values
are mean S.D. (n 3 per genotype, per age group); **, p 0.01.
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of LIF expression in Nucling-KO glands. Previous studies
reported that, LIF activated STAT3 via gp130, which is nor-
mally up-regulated after weaning to activate STAT3 (5, 6, 38).
Our results indicated that the loss of Nucling inhibited the gene
expression of gp130. Therefore the down-regulation of STAT3
activation observed in Nucling-KOmice may have been due to
FIGURE 6. Blockage of STAT3 activity during involution in Nucling-KOmice. A,Western blot analysis of STAT3 and phosphorylated STAT3 expression
during involution. Protein samples were prepared from the mammary glands of WT and Nucling-KO mice at 0, 36, and 72 h of involution. B, the
quantification of immunoblots for STAT3/-actin. The bar graph shows the relative density of the bands normalized to WT at 0 h involution. C,
quantification of immunoblots for p-STAT3/-actin. The bar graph shows the relative density of the bands normalized to WT at 0 h of involution.
D, quantification of the mRNA expression of C/EBP in mammary glands of WT and Nucling-KO mice at 0, 36, and 72 h of involution by quantitative
RT-PCR. Data were normalized with those of WT mice at 0 h of involution and represent mean S.D. Data were represented as mean S.D. (n 3 per
genotype, per age group). **, p  0.01.
FIGURE 7. Loss of Nucling resulted in suppression of gp130 expres-
sion. Quantitative RT-PCR analysis of (A) LIF and (B) gp130 mRNA expres-
sion is shown. Total RNA samples were prepared from the mammary
glands of WT and Nucling-KO mice during involution 0, 36, and 72 h. Data
were normalized with those of WT mice at 0 h of involution and repre-
sented as mean S.D. (n 3 per genotype, per age group). *, p 0.05; **,
p  0.01.
FIGURE 8. Loss of Nucling did not affect the expression of Sim2s during
involution. Quantification of the mRNA expression of Sim2s in mammary
glands of WT and Nucling-KOmice at 0, 36, and 72 h of involution by quanti-
tative RT-PCR. Data were normalized with those of WT mice at 0 h of involu-
tion and representmean S.D. Datawere represented asmean S.D. (n 3
per genotype, per age group). *, p 0.05.
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the inhibition of gp130 up-regulation during involution. Taken
together, our results identified Nucling as an essential effector
of STAT3 signaling via gp130 after weaning. The Nucling-de-
pendent up-regulation of gp130 is regulated by a novel alterna-
tive pathway to the LIF-related pathway. However, the role of
Nucling in the regulation of gp130 awaits further studies.
The absence of Nucling reduced the number of M2 macro-
phages present at 72 h of involution, indicating that Nucling is
important for the recruitment of M2 macrophages. We attrib-
uted the presence of small numbers of M2 macrophages in
Nucling-KO glands to two possible causes: it may be a conse-
quence of the down-regulated expression of cytokines as well as
lack of resident tissuemacrophages within themammary gland
due to delayed involution when Nucling is deleted. It may also
be due to the inhibited activation of STAT3 in Nucling-KO
mice. A previous study demonstrated that STAT3 activity
directly or indirectly modulated M2 macrophage populations
in postlactational mammary gland involution (27).
A previous study found that Sim2s is an inhibitor of NF-B
and STAT3 activity in postlactational involution. Overexpres-
sion of Sim2s results in delayed involution (28). In contrast,
herein, we revealed thatNucling activatesNF-B and STAT3 to
mediate involution. After weaning, the decrease in the expres-
sion of Sim2s was insufficient to induce involution in the
absence of Nucling. Therefore, the present study demonstrated
that Nucling is a novel factor that plays an important physio-
logical role in regulation of mammary gland involution.
At present, much of the evidence pointed to a correlation
between delayed postlactational involution and increase in
breast cancer formation (1). Nucling-KO mice have shown
delayed involution but breast tumors were not observed in
these mice. This may due to the suppression of important
NF-B and STAT3 signalings, which are essential for progres-
sion of breast tumor. Moreover, we have observed that the
absence of Nucling in postpartum female nudemice resulted in
formation of breast tumor in four of 20 mice. Although there
was no tumor bearing mice in more than 20 postpartum
females of nudemice. This suggests that cellular immunity sup-
pressed the breast tumor development in Nucling-KO mice.
Postlactational involution is a complex multistep process
that displays similar characteristics to the microenvironments
present during wound healing and tumor progression (39). The
activation of NF-B and STAT3 are essential for the progres-
sion of breast cancer, and their inhibition has been shown to
cause cell death and the suppression of breast tumors (40, 41).
Because a regulatory connection was identified between
NF-B/STAT3 activity andNucling inmammary gland involu-
tion in the present study, we postulated that this connection
may extend to breast cancer. More specifically, if Nucling is
strongly expressed in breast cancer, its inhibitionmay suppress
the activation of NF-B as well as STAT3, leading to the sup-
pression of the pro-oncogenic activities of these transcription
factors. Therefore, Nucling signaling needs to be examined in
more detail in breast cancer, so that effective inhibitors of
breast tumor progression can be developed in the future.
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